Learn More
Medchemexpress LLC Rig012 | 2642218-43-5 | ≥99.0% | C23H21NO3 | 10MG

Supplier: Medchemexpress LLC HY14712410MG
RIG012 is a small-molecule antagonist of the RIG-I innate immune receptor. It inhibits RIG-I ATPase activity (IC50 = 0.71 μM, NADH-coupled ATPase assay) and suppresses downstream signaling, including interferon-β and ISG expression. Supplied as a research-grade solid for in vitro studies; not for human or diagnostic use.
- Potent RIG-I inhibition (IC50 0.71 μM).
- Activity measured by NADH-coupled ATPase assay.
- Suppresses IFN-β and ISG expression in cellular assays.
- Supplied as a purified small-molecule for research use.
- Product datasheet and safety data sheet available for handling information.
- Useful for studying innate immune signaling and antiviral responses.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.